Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) was down 6.7% on Thursday . The stock traded as low as GBX 42.77 and last traded at GBX 46.67. 386,473 shares changed hands during mid-day trading, an increase of 152% from the average session volume of 153,287 shares. The stock had previously closed at GBX 50.
Beximco Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 5.27, a current ratio of 4.13 and a quick ratio of 0.37. The company has a market capitalization of £209.67 million, a PE ratio of 0.03 and a beta of 0.61. The stock’s 50 day simple moving average is GBX 43.03 and its 200-day simple moving average is GBX 42.74.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- MarketBeat Week in Review – 06/29 – 07/03
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
